Pecularities of drug therapy of coronary artery disease in combination with postmenopausal osteoporosis
| dc.contributor.author | Mykhailovska, N. S. | |
| dc.contributor.author | Stetsiuk, I. O. | |
| dc.contributor.author | Михайловська, Наталія Сергіївна | |
| dc.contributor.author | Стецюк, Ірина Олегівна | |
| dc.date.accessioned | 2025-04-01T07:32:30Z | |
| dc.date.available | 2025-04-01T07:32:30Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Aim of the study. To evaluate the clinical effectiveness of the supplementary inclusion of a combination of sodium alendronate and L-arginine hydrochloride to a basic treatment in women with coronary artery disease (CAD) comorbid with postmenopausal osteoporosis (PMOP). | uk_UK |
| dc.identifier.citation | Mykhailovska N. S. Pecularities of drug therapy of coronary artery disease in combination with postmenopausal osteoporosis : [тези наук.-практ. конф. “Всеукраїнський ревматологічний форум - 2024” з міжнар. участю, 23-25 жовт. 2024 р.] / N. S. Mykhailovska, I. O. Stetsiuk // Український ревматологічний журнал. - 2024. - N 3. - С. 49. | uk_UK |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/22290 | |
| dc.language.iso | en | uk_UK |
| dc.subject | тези доповідей | uk_UK |
| dc.title | Pecularities of drug therapy of coronary artery disease in combination with postmenopausal osteoporosis | uk_UK |
| dc.type | Other | uk_UK |